T3 Pharmaceuticals
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Klingelbergstr. 50-70, Basel, Basel-City...Phone Number
+41 612072074Website
www.t3pharma.comRevenue
<$5 MillionIndustry
About T3 Pharmaceuticals
Is T3 Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
T3 Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if T3 Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if T3 Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when T3 Pharmaceuticals launches new products
Funding: Get notified immidiatlly once T3 Pharmaceuticals has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if T3 Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at T3 Pharmaceuticals
Earning: See what the market has to say on T3 Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
T3 Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
T3 Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about T3 Pharmaceuticals.
T3 Pharmaceuticals financials insights
Gather financial insights about T3 Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$13.3M
Series C
$26.9M
T3 Pharmaceuticals Tech Stack
Most Recent Scoops
T3 Pharmaceuticals News & Media
T3 Pharmaceuticals AG's CHF19.3 Million Series C Financing Round
VISCHER advises T3 Pharmaceuticals AG on all legal issues related to the transaction. T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based …T3 Pharma raises 25M CHF to advance bacterial cancer therapy through clinic
BASEL, Switzerland--(BUSINESS WIRE)--T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, today announced the closing of its third financing round, raising over 25M CHF. The financing was co-led by existing investors, including the Boehringer Ingelheim Venture Fund (BIVF), Reference Capital SA, Wille Finance AG and private investors, who all participated in the round. This latest financing brings T3 Pharma’s total fundBioSpace Global Roundup, Oct. 3
Companies from across the globe share information on their business and pipelines.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding T3 Pharmaceuticals
T3 Pharma is a biotechnology company focused on developing innovative therapies in the fields of immuno-oncology and targeted therapies. The company aims to address unmet medical needs in cancer treatment through its advanced technology and research pipeline. T3 Pharma's intended clients include healthcare providers and patients seeking effective c... Read More